Johnson Matthey (OTCMKTS:JMPLY) Sets New 12-Month High - Here's What Happened

Key Points

• Shares of Johnson Matthey PLC reached a new 52-week high of $56.55 during mid-day trading, closing at $56.48.
• Equities research analysts have upgraded Johnson Matthey's rating, with Zacks Research moving it from "hold" to a "strong-buy" rating.
• The company maintains solid financial metrics, including a quick ratio of 1.01 and a debt-to-equity ratio of 0.57.

Shares of Johnson Matthey PLC (OTCMKTS:JMPLY - Get Free Report) hit a new 52-week high during mid-day trading on Tuesday . The company traded as high as $56.55 and last traded at $56.48, with a volume of 1632 shares trading hands. The stock had previously closed at $55.33.

Wall Street Analyst Weigh In

A number of equities research analysts have recently issued reports on the stock. Zacks Research raised shares of Johnson Matthey from a "hold" rating to a "strong-buy" rating in a research report on Wednesday, October 8th. Kepler Capital Markets raised shares of Johnson Matthey to a "hold" rating in a research report on Wednesday, June 25th. One investment analyst has rated the stock with a Strong Buy rating and one has issued a Hold rating to the company. According to data from MarketBeat, the company presently has an average rating of "Buy".

Johnson Matthey Stock Up 2.1%

The company has a quick ratio of 1.01, a current ratio of 1.42 and a debt-to-equity ratio of 0.57. The firm's fifty day moving average is $51.79 and its two-hundred day moving average is $45.34.

About Johnson Matthey

Johnson Matthey is a global leader in science that enables a cleaner and healthier world. With over 200 years of sustained commitment to innovation and technological breakthroughs, they improve the function, performance and safety of their customers' products. Their science has a global impact in areas such as low emission transport, pharmaceuticals, chemical processing and making the most efficient use of the planet's natural resources.

This instant news alert was generated by narrative science technology and financial data from MarketBeat in order to provide readers with the fastest and most accurate reporting. This story was reviewed by MarketBeat's editorial team prior to publication. Please send any questions or comments about this story to contact@marketbeat.com.